Nascent Biotech Inc. (NBIO) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
631 US HWY 1, SUITE 407 NORTH PALM BEACH, FL 33408 |
| State of Incorp. | NV |
| Fiscal Year End | March 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 6/30/2024 MRQ | 3/31/2024 | 12/31/2023 MRQ | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 172,186 | 94,414 | 1,435 | 3,218 | |||||
| Cash and cash equivalents | 172,186 | 94,414 | 1,435 | 3,218 | |||||
| Receivables | 750,000 | ||||||||
| Prepaid expense | 180,000 | 17,442 | |||||||
| Other undisclosed current assets | 372,120 | 624,254 | 82,816 | 11,000 | |||||
| Total current assets: | 552,120 | 641,696 | 255,002 | 105,414 | 751,435 | 3,218 | |||
| Noncurrent Assets | |||||||||
| Other undisclosed noncurrent assets | (400) | ||||||||
| Total noncurrent assets: | (400) | ||||||||
| TOTAL ASSETS: | 552,120 | 641,296 | 255,002 | 105,414 | 751,435 | 3,218 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 686,294 | 483,751 | 498,122 | 776,890 | 636,831 | 852,664 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 9,972 | ||||
| Accounts payable | 27,000 | 852,664 | |||||||
| Accrued liabilities | 5,240 | 700,000 | 28,000 | ||||||
| Other undisclosed accounts payable and accrued liabilities | 686,294 | 478,511 | (201,878) | 711,918 | 636,831 | ||||
| Debt | 122,500 | 125,000 | 389,591 | 161,736 | 50,000 | ||||
| Due to related parties | ✕ | ✕ | ✕ | 123,217 | 1,283,607 | ||||
| Other undisclosed current liabilities | 2,179 | 663,426 | 302,156 | 692,651 | |||||
| Total current liabilities: | 808,794 | 610,930 | 1,551,139 | 776,890 | 1,223,940 | 2,878,922 | |||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 808,794 | 610,930 | 1,551,139 | 776,890 | 1,223,940 | 2,878,922 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (256,674) | 30,367 | (1,296,137) | (671,476) | (472,505) | (2,875,704) | |||
| Preferred stock | 60 | ||||||||
| Common stock | 170,594 | 168,729 | 131,764 | 111,313 | 104,834 | 44,890 | |||
| Additional paid in capital | 23,833,189 | 23,609,519 | 20,194,874 | 18,039,017 | 17,774,023 | 13,916,995 | |||
| Accumulated deficit | (24,260,457) | (23,747,881) | (21,622,775) | (18,821,806) | (18,351,416) | (16,837,649) | |||
| Other undisclosed equity, attributable to parent | 54 | ||||||||
| Other undisclosed equity | (1) | ||||||||
| Total equity: | (256,674) | 30,366 | (1,296,137) | (671,476) | (472,505) | (2,875,704) | |||
| TOTAL LIABILITIES AND EQUITY: | 552,120 | 641,296 | 255,002 | 105,414 | 751,435 | 3,218 | |||
Income Statement (P&L) (USD)
| 6/30/2024 TTM | 3/31/2024 | 12/31/2023 TTM | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 135 | 274 | 1,000,000 | 750,000 | ||||
| Gain on disposition of assets for financial service operations | 468,823 | |||||||
| Net investment income | 135 | 274 | 12 | 5 | ||||
| Cost of revenue (Cost of Goods and Services Sold) | (319,507) | (1,688) | ||||||
| Other undisclosed gross profit | ||||||||
| Gross profit: | (319,507) | (1,553) | 274 | 1,000,000 | 750,000 | |||
| Operating expenses | (2,229,879) | (4,144,808) | (2,155,757) | (1,457,052) | (681,197) | (614,639) | ||
| Other undisclosed operating income (loss) | 319,507 | 1,892,690 | (274) | (1,469,171) | (2,832,672) | |||
| Operating loss: | (2,229,879) | (2,253,671) | (2,155,757) | (457,052) | (1,400,368) | (3,447,311) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 142,197 | 160,507 | (645,212) | (13,338) | 441,601 | (556,848) | ||
| Interest and debt expense | 50,000 | (75,234) | 28,000 | (48,044) | 151,308 | (86,632) | ||
| Loss from continuing operations before equity method investments, income taxes: | (2,037,682) | (2,168,398) | (2,772,969) | (518,434) | (807,459) | (4,090,791) | ||
| Other undisclosed income from continuing operations before income taxes | 28,000 | 86,638 | ||||||
| Loss from continuing operations: | (2,037,682) | (2,140,398) | (2,772,969) | (518,434) | (807,459) | (4,004,153) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (518,434) | (807,459) | (4,004,153) | |
| Other undisclosed net income (loss) | (50,000) | 5,573,938 | 5,573,938 | |||||
| Net income (loss): | (2,087,682) | 3,433,540 | 2,800,969 | (518,434) | (807,459) | (4,004,153) | ||
| Other undisclosed net income (loss) attributable to parent | (5,526,705) | (5,601,938) | 48,044 | (151,308) | ||||
| Net loss available to common stockholders, diluted: | (2,087,682) | (2,093,165) | (2,800,969) | (470,390) | (958,767) | (4,004,153) | ||
Comprehensive Income (USD)
| 6/30/2024 TTM | 3/31/2024 | 12/31/2023 TTM | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (2,087,682) | 3,433,540 | 2,800,969 | (518,434) | (807,459) | (4,004,153) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (2,087,682) | 3,433,540 | 2,800,969 | (518,434) | (807,459) | (4,004,153) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.